James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s Episcopal Hospital, discusses groundbreaking new therapies to cure cardiovascular disease using stem cell technology. He expounds upon using induced differentiation of autologous fibroblasts to create contracting muscle cells in culture that can then be used to repair heart muscle.

Read more about James T. Willerson.

Read more about the current stem cell research happening at  the Texas Heart Institute.